Next Article in Journal
Glomangioma Supply from Profunda Femoris Artery in Peripheral Artery Disease
Previous Article in Journal
Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Clinics and Practice
Volume 12
Issue 5
10.3390/clinpract12050077
clinpract-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Review of Pediatric Tuberculosis in the Aftermath of COVID-19

by
Patrida Rangchaikul
,
Phillip Ahn
,
Michelle Nguyen
,
Vivian Zhong
and
Vishwanath Venketaraman
*
College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91710, USA
*
Author to whom correspondence should be addressed.
Clin. Pract. 2022, 12(5), 738-754; https://doi.org/10.3390/clinpract12050077
Submission received: 18 August 2022 / Revised: 6 September 2022 / Accepted: 8 September 2022 / Published: 11 September 2022
Browse Figures
Review Reports Versions Notes

Abstract

In 2014, the World Health Organization developed the End Tuberculosis Strategy with the goal of a 95% reduction in deaths from tuberculosis (TB) by 2035. The start of the COVID-19 pandemic and global lockdown has had a major impact on TB awareness, screening, diagnosis, and prompt initiation of treatment, inevitably leading to a significant setback. We explore pediatric tuberculosis through the lens of the COVID-19 era, investigating how COVID-19 has impacted pediatric TB cases in different regions of the world and what the implications are for management moving forward to mitigate these effects. Furthermore, in light of recent findings showing how exposed infants and children are at higher risk than we thought of contracting the disease, greater attention and resources are needed to prevent further downward trends.
Keywords: tuberculosis; pediatrics; COVID-19; SARS-CoV-2; immunology; prevention tuberculosis; pediatrics; COVID-19; SARS-CoV-2; immunology; prevention

Share and Cite

MDPI and ACS Style

Rangchaikul, P.; Ahn, P.; Nguyen, M.; Zhong, V.; Venketaraman, V. Review of Pediatric Tuberculosis in the Aftermath of COVID-19. Clin. Pract. 2022, 12, 738-754. https://doi.org/10.3390/clinpract12050077

AMA Style

Rangchaikul P, Ahn P, Nguyen M, Zhong V, Venketaraman V. Review of Pediatric Tuberculosis in the Aftermath of COVID-19. Clinics and Practice. 2022; 12(5):738-754. https://doi.org/10.3390/clinpract12050077

Chicago/Turabian Style

Rangchaikul, Patrida, Phillip Ahn, Michelle Nguyen, Vivian Zhong, and Vishwanath Venketaraman. 2022. "Review of Pediatric Tuberculosis in the Aftermath of COVID-19" Clinics and Practice 12, no. 5: 738-754. https://doi.org/10.3390/clinpract12050077

APA Style

Rangchaikul, P., Ahn, P., Nguyen, M., Zhong, V., & Venketaraman, V. (2022). Review of Pediatric Tuberculosis in the Aftermath of COVID-19. Clinics and Practice, 12(5), 738-754. https://doi.org/10.3390/clinpract12050077

Article Metrics

Back to TopTop